Corrigendum: The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside

• María B. Birkisdóttir,
• María B. Birkisdóttir,
• Ivar van Galen,
• Ivar van Galen,
• Renata M. C. Brandt,
• Sander Barnhoorn,
• Nicole van Vliet,
• Claire van Dijk,
• Claire van Dijk,
• Bhawani Nagarajah,
• Sandra Imholz,
• Conny T. van Oostrom,
• Erwin Reiling,
• Ákos Gyenis,
• Pier G. Mastroberardino,
• Pier G. Mastroberardino,
• Pier G. Mastroberardino,
• Dick Jaarsma,
• Harry van Steeg,
• Jan H. J. Hoeijmakers,
• Jan H. J. Hoeijmakers,
• Jan H. J. Hoeijmakers,
• Jan H. J. Hoeijmakers,
• Martijn E. T. Dollé,
• Wilbert P. Vermeij,
• Wilbert P. Vermeij

Affiliations

María B. Birkisdóttir

Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

María B. Birkisdóttir

Oncode Institute, Utrecht, Netherlands

Ivar van Galen

Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Ivar van Galen

Oncode Institute, Utrecht, Netherlands

Renata M. C. Brandt

Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands

Sander Barnhoorn

Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands

Nicole van Vliet

Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands

Claire van Dijk

Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands

Claire van Dijk

Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands

Bhawani Nagarajah

Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands

Sandra Imholz

Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands

Conny T. van Oostrom

Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands

Erwin Reiling

Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands

Ákos Gyenis

Faculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany

Pier G. Mastroberardino

Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands

Pier G. Mastroberardino

IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy

Pier G. Mastroberardino

Department of Life, Health, and Environmental Sciences, University of L'Aquila, L'Aquila, Italy

Dick Jaarsma

Department of Neuroscience, Erasmus University Medical Center, Rotterdam, Netherlands

Harry van Steeg

Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands

Jan H. J. Hoeijmakers

Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Jan H. J. Hoeijmakers

Oncode Institute, Utrecht, Netherlands

Jan H. J. Hoeijmakers

Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands

Jan H. J. Hoeijmakers

Faculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany

Martijn E. T. Dollé

Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands

Wilbert P. Vermeij

Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Wilbert P. Vermeij

Oncode Institute, Utrecht, Netherlands